PSI is a non-profit organisation formed in 1977 which provides a forum for regular discussion of statistics and issues relating to the practice of statistics in the pharmaceutical industry, as well as promoting good statistical practice within the industry.

Why join PSI


We provide...

opportunities for our members to network, develop themselves and shape the industry

We are...

run by our membership through a network of committees and special interest groups

We promote...

best statistical practice to our members and promote the value of statistics to the external world

Statisticians in the Pharmaceutical Industry
Executive Office: Durford Mill, Petersfield, Hampshire, GU31 5AZ e: PSI@MCI-group.com t: +44 (0)1730 715 235 

EventsFuture Events


  • 1st EFSPI Workshop on Regulatory Statistics - Dates: 12 – 13 Sep, 2016

    Our first Statistical Workshop will be dedicated to opportunities and challenges of statistical topics between regulators, academics and industry with dedicated time for interaction and discussion.
  • Time-to-Event and Recurrent Event Endpoints - Dates: 14 – 14 Sep, 2016

    This exciting one-day workshop will cover a wide range of statistical aspects relating to event-driven trials. This is a joint event with the BBS (Basel Biometric Section of the Austro-Swiss Region of the IBS);
  • Second Membership Town Hall: PSI/RSS merger - Dates: 15 – 15 Sep, 2016

    Calling all PSI members to register for the upcoming debate regarding the proposed PSI/RSS merger. Hear the arguments for and against the proposal and have the opportunity to ask questions of representatives for each campaign and the RSS.
  • Introduction To Industry Training Course 2016 - Dates: 01 Oct, 2016 – 31 Jul, 2017

    AIM: To describe the drug development process from research right through to research, toxicology, data management & role of the CRO, clinical trials, product development & manufacture and marketing.
  • PSI One Day Meeting: Sample Size Re-estimation – dealing with those known unknowns! - Dates: 02 – 02 Nov, 2016

    The aim of this PSI one day meeting is to present an overview of available methods for sample size re-estimation together with several case studies where such methods have been used in late phase clinical trials.
  • Dose Finding in Drug Development using MCP-Mod - Dates: 01 – 02 Mar, 2017

    This course will introduce and discuss methods for Phase II dose finding studies, including a review of basic multiple comparisons and modelling methods, as traditionally used in these studies. A unified strategy for designing and analysing dose finding trials denoted MCP-Mod, combining multiple comparisons and modelling, will be the focus of the course.